Drug interactions between Coricidin HBP Nighttime Multi-Symptom Cold and Relief
|Coricidin HBP Nighttime Multi-Symptom Cold (acetaminophen/dextromethorphan/doxylamine)|
|Relief (phenylephrine ophthalmic)|
Interactions between your drugs
There were no interactions found in our database between Coricidin HBP Nighttime Multi-Symptom Cold and Relief - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Coricidin HBP Nighttime Multi-Symptom Cold
- Coricidin HBP Nighttime Multi-Symptom Cold is in the drug class upper respiratory combinations.
- Coricidin HBP Nighttime Multi-Symptom Cold is used to treat the following conditions:
A total of 165 drugs are known to interact with Relief.
- Relief is a member of the following drug classes: mydriatics, ophthalmic antihistamines and decongestants.
- Relief is used to treat the following conditions:
Drug and food interactions
Applies to: Coricidin HBP Nighttime Multi-Symptom Cold (acetaminophen / dextromethorphan / doxylamine)
Alcohol can increase the nervous system side effects of doxylamine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with doxylamine. Do not use more than the recommended dose of doxylamine, and avoid activities requiring mental alertness such as driving or operating hazardous machinery until you know how the medication affects you. Talk to your doctor or pharmacist if you have any questions or concerns.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.